Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Jan 5;6(1):e000368.
doi: 10.1136/bmjresp-2018-000368. eCollection 2019.

MesoTRAP: a feasibility study that includes a pilot clinical trial comparing video-assisted thoracoscopic partial pleurectomy decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial

Claire Matthews  1 , Carol Freeman  1 , Linda D Sharples  2 , Julia Fox-Rushby  3 , Angela Tod  4 , Nicholas A Maskell  5 , John G Edwards  6 , Aman S Coonar  7 , Pasupathy Sivasothy  8 , Victoria Hughes  1 , Najib M Rahman  9 , David A Waller  10 , Robert Campbell Rintoul  1   11
Affiliations
Comparative Study

MesoTRAP: a feasibility study that includes a pilot clinical trial comparing video-assisted thoracoscopic partial pleurectomy decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial

Claire Matthews et al. BMJ Open Respir Res. .

Abstract

Introduction: One of the most debilitating symptoms of malignant pleural mesothelioma (MPM) is dyspnoea caused by pleural effusion. MPM can be complicated by the presence of tumour on the visceral pleura preventing the lung from re-expanding, known as trapped lung (TL). There is currently no consensus on the best way to manage TL. One approach is insertion of an indwelling pleural catheter (IPC) under local anaesthesia. Another is video-assisted thoracoscopic partial pleurectomy/decortication (VAT-PD). Performed under general anaesthesia, VAT-PD permits surgical removal of the rind of tumour from the visceral pleura thereby allowing the lung to fully re-expand.

Methods and analysis: MesoTRAP is a feasibility study that includes a pilot multicentre, randomised controlled clinical trial comparing VAT-PD with IPC in patients with TL and pleural effusion due to MPM. The primary objective is to measure the SD of visual analogue scale scores for dyspnoea following randomisation and examine the patterns of change over time in each treatment group. Secondary objectives include documenting survival and adverse events, estimating the incidence and prevalence of TL in patients with MPM, examining completion of alternative forms of data capture for economic evaluation and determining the ability to randomise 38 patients in 18 months.

Ethics and dissemination: This study was approved by the East of England-Cambridge Central Research Ethics Committee and the Health Research Authority (reference number 16/EE/0370). We aim to publish the outputs of this work in international peer-reviewed journals compliant with an Open Access policy.

Trial registration: NCT03412357.

Keywords: asbestos induced lung disease; mesothelioma; pleural disease; thoracic surgery.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Study flow chart. IPC, indwelling pleural catheter; MPM, malignant pleural mesothelioma; VAT-PD, video-assisted thoracoscopic partial pleurectomy decortication. MesoTRAP Investigators (6 August 2018).
See this image and copyright information in PMC

References

    1. Current asbestos ban. 2018. Available from: http://ibasecretariat.org/alpha_ban_list.php [Accessed 16 Jul 2018].
    1. Odgerel CO, Takahashi K, Sorahan T, et al. . Estimation of the global burden of mesothelioma deaths from incomplete national mortality data. Occup Environ Med 2017;74:851–8. 10.1136/oemed-2017-104298 - DOI - PMC - PubMed
    1. Asbestos related disease. 2018. Available from: http://www.hse.gov.uk/Statistics/causdis/asbestos.htm [Accessed 27 Mar 2018].
    1. Hodgson JT, McElvenny DM, Darnton AJ, et al. . The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005;92:587–93. 10.1038/sj.bjc.6602307 - DOI - PMC - PubMed
    1. Beckett P, Edwards J, Fennell D, et al. . Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer 2015;88:344–8. 10.1016/j.lungcan.2015.03.005 - DOI - PubMed

Publication types

MeSH terms

Associated data